Siloam is seeking strategic partnerships with assay development and instrumentation companies wishing to leverage the power of Optimiser's™ enabling platform technology to improve their current assay systems. Optimiser™ platform technologies provide unheard of flexibility for researchers using existing immunoassay instrumentation. Researchers select the sensitivity levels desired for their specific research needs and have the ability to optimise for sample savings and speed, all on one microplate, with Optimiser’s™ unique microfluidic platform embedded within a traditional microtiter plate format.
ADO Price at posting:
6.1¢ Sentiment: None Disclosure: Not Held
